MUSTANG BIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $112.4M | $109.6M |
| FY2022 | — | $46.3M | $75.7M |
| FY2023 | — | $123.0K | $6.2M |
| FY2024 | — | $-3.9M | $6.8M |
| FY2025 | — | $9.5M | $17.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $112.4M | $109.6M |
| FY2022 | — | $46.3M | $75.7M |
| FY2023 | — | $123.0K | $6.2M |
| FY2024 | — | $-3.9M | $6.8M |
| FY2025 | — | $9.5M | $17.3M |